Human medicines European public assessment report (EPAR): NexoBrid, concentrate of proteolytic enzymes enriched in bromelain, Date of authorisation: 18/12/2012, Revision: 17, Status: Authorised

Submitted by Anonymous (not verified) on 3 December 2025 - 14:51

Human medicines European public assessment report (EPAR): NexoBrid, concentrate of proteolytic enzymes enriched in bromelain, Date of authorisation: 18/12/2012, Revision: 17, Status: Authorised

Link: 
https://www.ema.europa.eu/en/medicines/human/EPAR/nexobrid
Source: 
What's new

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More